Western Pacific (WHO region) vs Yemen: Previously treated cases tested for RR-/MDR-TB
Western Pacific (WHO region)
86.0%
in 2024
Yemen
100.0%
in 2024
Western Pacific (WHO region) rank
3rd
Yemen rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Western Pacific (WHO region)
- Yemen
How they compare
Yemen currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.
That makes Yemen's figure about 1.2 times Western Pacific (WHO region)'s.
The two have swapped places 2 times across 17 shared years of data; in 2006 it was Yemen ahead.
Western Pacific (WHO region) ranks 3rd and Yemen ranks 1st of 11 groups.
Across the 3 decades both report, Western Pacific (WHO region) averaged higher in 2 and Yemen in 1.
Head to head by decade
| Decade | Western Pacific (WHO region) | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.1% | 11.2% | 10.1% | Yemen |
| 2010s | 55.9% | 21.5% | 34.5% | Western Pacific (WHO region) |
| 2020s | 89.2% | 60.0% | 29.2% | Western Pacific (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Western Pacific (WHO region) or Yemen?
- Yemen, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Western Pacific (WHO region) and Yemen?
- 14.0%, with Yemen ahead.
- How many years of comparable data are there for Western Pacific (WHO region) and Yemen?
- 17 years are reported by both, from 2006 to 2024.
- How do Western Pacific (WHO region) and Yemen rank globally for previously treated cases tested for rr-/mdr-tb?
- Western Pacific (WHO region) ranks 3rd and Yemen ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.